Vienna's biotech sector grew to €22.7 billion in 2023, driven by advances in research, innovation, and workforce expansion, positioning the city as a burgeoning life sciences hub. Concurrently, the European Commission imposed fines on Alchem for participating in an API cartel, closing a long-running investigation. These developments highlight both growth opportunities and regulatory challenges within European biotech markets.